MEDEVA SEMPREX-D (Semprex-D 8 mg-60 mg)
Generic Name: acrivastine/pseudoephedrine
Pill with imprint MEDEVA SEMPREX-D is Green & White, Capsule-shape and has been identified as Semprex-D 8 mg-60 mg. It is supplied by Celltech Pharmaceuticals Inc..
Semprex-D is used in the treatment of allergic rhinitis; nasal congestion and belongs to the drug class upper respiratory combinations. There is no proven risk in humans during pregnancy. Semprex-D 8 mg-60 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MEDEVA SEMPREX-D
Semprex-D
- Generic Name:
- acrivastine/pseudoephedrine
- Imprint:
- MEDEVA SEMPREX-D
- Strength:
- 8 mg-60 mg
- Color:
- Green & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Celltech Pharmaceuticals Inc.
- Inactive Ingredients:
- lactose
magnesium stearate
sodium starch glycolate
gelatin
D&C Yellow No. 10
FD&C Green No. 3
titanium dioxide
Note: Inactive ingredients may vary.
More about Semprex-D (acrivastine / pseudoephedrine)
- Semprex-D Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: upper respiratory combinations
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
